ATOS · Atossa Therapeutics, Inc. · Off Exchange
$1.65
-0.10 (-5.71%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2023 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Substantial doubt exists about our ability to continue as a going concern.”View the 10-Q filed Nov 10, 2026
Market Cap
$15.92M
Shares
9.98M
Volume · Nov 20
48.93K
Avg daily vol (3M)
67.59K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-10-12 | 83,638 | 288,816 | 372,454 | 51.5% |
| 2026-10-05 | 44,908 | 157,693 | 202,601 | 41.0% |
| 2026-09-28 | 68,269 | 195,496 | 263,765 | 53.6% |
| 2026-09-21 | 36,119 | 164,941 | 201,060 | 57.6% |
| 2026-09-14 | 27,038 | 68,284 | 95,322 | 48.2% |
| 2026-09-07 | 18,828 | 82,444 | 101,272 | 58.3% |
| 2026-08-31 | 39,548 | 135,787 | 175,335 | 63.8% |
| 2026-08-24 | 8,341 | 124,752 | 133,093 | 64.8% |
| 2026-08-17 | 21,115 | 188,510 | 209,625 | 51.1% |
| 2026-08-10 | 14,962 | 137,579 | 152,541 | 45.3% |
| 2026-08-03 | 16,572 | 102,517 | 119,089 | 52.9% |
| 2026-07-27 | 11,516 | 102,675 | 114,191 | 48.6% |
| 2026-07-20 | 35,720 | 103,093 | 138,813 | 42.4% |
| 2026-07-13 | 59,791 | 217,092 | 276,883 | 50.4% |
| 2026-07-06 | 64,498 | 462,319 | 526,817 | 53.1% |
| 2026-06-29 | 54,073 | 219,564 | 273,637 | 53.0% |
| 2026-06-22 | 151,592 | 682,870 | 834,462 | 45.6% |
| 2026-06-15 | 94,913 | 730,477 | 825,390 | 49.2% |
| 2026-06-08 | 271,932 | 1,063,164 | 1,335,096 | 61.1% |
| 2026-06-01 | 25,890 | 117,100 | 142,990 | 46.3% |
| 2026-05-25 | 18,776 | 68,594 | 87,370 | 53.0% |
| 2026-05-18 | 18,008 | 106,039 | 124,047 | 57.6% |
| 2026-05-11 | 17,138 | 87,794 | 104,932 | 51.0% |
| 2026-05-04 | 37,762 | 211,210 | 248,972 | 57.0% |
| 2026-04-27 | 20,437 | 60,559 | 80,996 | 52.0% |
| 2026-04-20 | 34,492 | 141,483 | 175,975 | 51.5% |
| 2026-04-13 | 39,973 | 93,038 | 133,011 | 45.0% |
| 2026-04-06 | 48,464 | 87,719 | 136,183 | 47.6% |
| 2026-03-30 | 23,572 | 91,734 | 115,306 | 53.2% |
| 2026-03-23 | 40,303 | 154,278 | 194,581 | 45.7% |
| 2026-03-16 | 51,180 | 119,123 | 170,303 | 45.3% |
| 2026-03-09 | 61,714 | 206,550 | 268,264 | 48.7% |
| 2026-03-02 | 33,702 | 200,739 | 234,441 | 52.6% |
| 2026-02-23 | 43,189 | 199,849 | 243,038 | 55.2% |
| 2026-02-16 | 34,513 | 105,820 | 140,333 | 46.6% |
| 2026-02-09 | 88,221 | 457,968 | 546,189 | 45.3% |
| 2026-02-02 | 170,303 | 972,950 | 1,143,253 | 58.8% |
| 2026-01-26 | 41,907 | 483,338 | 525,245 | 100.0% |
| 2026-01-19 | 30,123 | 236,860 | 266,983 | 100.0% |
| 2026-01-12 | 29,246 | 484,748 | 513,994 | 100.0% |
| 2026-01-05 | 18,810 | 199,816 | 218,626 | 100.0% |
| 2025-12-29 | 49,979 | 346,761 | 396,740 | 100.0% |
| 2025-12-22 | 16,413 | 194,647 | 211,060 | 100.0% |
| 2025-12-15 | 28,281 | 217,730 | 246,011 | 100.0% |
| 2025-12-08 | 26,692 | 355,100 | 381,792 | 100.0% |
| 2025-12-01 | 23,808 | 154,938 | 178,746 | 100.0% |
| 2025-11-24 | 10,193 | 68,218 | 78,411 | 100.0% |
Showing 1–47 of 47 weeks
Key facts
CIK
1488039
CUSIP
04962H704
13F (30d)
61 filings
35 filers
Visit website
Investor relations